Last reviewed · How we verify

NCT05147025

Evaluation of Retreatment of Failed Revasculatized Teeth by Revascularization

Status unknown NA Last updated 7 December 2021
What this trial tests

NA trial testing Revascularization in Revascularization in 60 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
1 December 2023
1 January 2024

Quick facts

Lead sponsorMinia University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 December 2021
Primary completion1 December 2023
Estimated completion1 January 2024

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 8 to 10, any sex, with Revascularization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study will include 30 participants with failed revascularized young permenant teeth that will be retreated by revascularization and evaluated for success through 2 years

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Revascularization

Trials testing the same drug.

Other recruiting trials for Revascularization

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05147025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing